KV-C19

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKV-C19
Drug Alias Nameimmunotherapeutic vaccine (Key Capital)KV-C19
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKey Capital Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKey Capital Corp
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A